Skip to main content

PreveCeutical Medical, Sol-Gel CBD Nasal Delivery Platform, an Innovation in the Cannabis Sector

NEW YORK, NY / ACCESSWIRE / July 19, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on PreveCeutical Medical Inc. (OTCQB: PRVCF), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.

The Company's Sol-gel Program uses five distinct Cannabis sativa L. strains containing a broad range of CBD: THC concentrations, which allows for the development of medicinal cannabis products tailored for a broad range of ailments and diseases.

Get all the Sol-gel details and info on the other products at PreveCeutical READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/preveceutical-medical/

The company has inked a non-disclosure agreement with a globally recognized, innovative drug delivery device manufacturer. This will allow the firm to enter discussions with the manufacturer for the supply of spray devices for use in the company's soluble gel drug delivery research program.

The Company also has a strategic partnership with Aurora Cannabis, a leading producer and distributor of high-grade medical cannabis and the relationship is key to PreveCeutical in securing the supply of cannabinoids that are consistent and of the highest quality.

Read about the company's recent highlights and their 2018 guidance READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/preveceutical-medical/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.